Author

K. Kanjo

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2 Biophysics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:drug response / drug discovery· 2 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1 Assay:protein sequence· 1 Assay:proteomics· 1 Organism:rat· 1

Frequent Co-Authors

R. Singh· 3 shared R. Varadarajan· 3 shared A. Tyagi· 2 shared A. Upadhyaya· 2 shared D. Chakraborty· 2 shared I. Pramanick· 2 shared M. S. Khan· 2 shared N. Girish· 2 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersMicrobiology

R. Singh

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Mutations in S2 subunit of SARS-CoV-2 Omicron spike strongly influence its conformation, fusogenicity and neutralization sensitivity

S. Kumar, R. Delipan, D. Chakraborty, K. Kanjo, R. Singh, N. Singh, S. Siddiqui, A. Tyagi, S. Jha, K. G. Thakur, R. Pandey, R. Varadarajan, R. P. Ringe

This study investigates how mutations in the S2 subunit of SARS-CoV-2 Omicron spike affect its structure, fusogenicity, and neutralization sensitivity.

bioRxiv · Mar 5, 2023Microbiology

Immunogenicity and protective efficacy of a highly thermotolerant, trimeric SARS-CoV-2 receptor binding domain derivative

S. K. Malladi, U. R. Patel, R. S. Rajmani, R. Singh, S. Pandey, S. Kumar, S. Khaleeq, P. J. v. Vuren, S. S. Riddell, S. Goldie, S. Gayathri, D. Chakraborty, P. Kalita, I. Pramanick, N. Agarwal, , R. Varadarajan

This study designs a thermotolerant trimeric RBD vaccine candidate that elicits strong neutralizing antibodies against multiple SARS-CoV-2 variants in animal models.

bioRxiv · Jan 13, 2021Microbiology

Design of a highly thermotolerant, immunogenic SARS-CoV-2 spike fragment

S. K. Malladi, R. Singh, S. Pandey, S. Gayathri, K. Kanjo, S. Ahmed, M. S. Khan, P. Kalita, N. Girish, A. Upadhyaya, P. Reddy, I. Pramanick, M. Bhasin, S. Mani, S. Bhattacharyya, , R. Varadarajan

This paper designs a thermotolerant, immunogenic SARS-CoV-2 RBD protein fragment that is stable at high temperatures and elicits neutralizing antibodies in guinea pigs.

bioRxiv · Aug 15, 2020Biophysics